Bioequivalence Study of Generic Drugs-6 (in the central nervous system diseases group) AI

TEDAS your procurement assistant

Ask a question about this procurement

t

The following is a summary of the current information regarding the procurement announced by AS Grindeks: # Procurement Object * Subject: Full-service bioequivalence (in vivo biological equivalence) study (Project 6) in the central nervous system diseases group. * Main requirements: * Study design, protocol development, CRF/ICF preparation. * Submission of documentation to regulatory authorities and the Ethics Committee. * Clinical phase, bioanalytical services, pharmacovigilance, pharmacokinetic calculations, statistical analysis, and preparation of the final report. *…
 
To see full summary, please log in or register.

t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

940042-1-P6-Pazin-par-iepirk-izsludin-6.docx

940042-2-P6-6-Iepirkuma-prieksm-apraksts-Patentbrivo-zalu-bioekviv-petijums-6.docx

940042-3-P6-Generic-drug-bioeq-study-6-EU-ENG.docx

Ready to get started?

Subscribe and enjoy all the benefits every day!